Does Librium (chlordiazepoxide) cause side effects?

Librium (chlordiazepoxide) is a long-acting benzodiazepine used to manage symptoms associated with anxiety disorders. Librium has anti-anxiety, sedative, appetite-stimulating, and weak pain-relieving properties. 

The exact mechanism of how Librium provides therapeutic benefits is not yet understood. However, current understanding of benzodiazepines indicates that they enhance or increase the activity of GABA, an inhibitory neurotransmitter, a chemical that cells in the brain use to suppress the activity of other cells.

Common side effects of Librium include

Serious side effects of Librium include

Drug interactions of Librium include drugs that inhibit cytochrome P450 3A4 enzymes, because they reduce the metabolism of Librium and have the potential for causing side effects.

Due to the risk of potential harm to the fetus, use of Librium during pregnancy is not recommended.

Librium is thought to be excreted into breast milk. Due to the lack of conclusive safety data, use in breastfeeding mothers is not recommended.

What are the important side effects of Librium (chlordiazepoxide)?

Reported side effects include:

Serious side effects that have been reported are:

  • Blood disorders
  • Jaundice
  • Liver dysfunction

Librium (chlordiazepoxide) side effects list for healthcare professionals

  • The necessity of discontinuing therapy because of undesirable effects has been rare.
  • Drowsiness, ataxia and confusion have been reported in some patients particularly the elderly and debilitated. While these effects can be avoided in almost all instances by proper dosage adjustment, they have occasionally been observed at the lower dosage ranges. In a few instances syncope has been reported.
  • Other adverse reactions reported during therapy include isolated instances of
  • Such side effects have been infrequent, and are generally controlled with reduction of dosage. Changes in EEG patterns (low-voltage fast activity) have been observed in patients during and after Librium (chlordiazepoxide) treatment.
  • Blood dyscrasias (including agranulocytosis), jaundice and hepatic dysfunction have occasionally been reported during therapy.
  • When Librium (chlordiazepoxide) treatment is protracted, periodic blood counts and liver function tests are advisable.

Does Librium (chlordiazepoxide) cause addiction or withdrawal symptoms?

  • Chlordiazepoxide hydrochloride capsules are classified by the Drug Enforcement Administration as a Schedule IV controlled substance.
  • Withdrawal symptoms, similar in character to those noted with barbiturates and alcohol (convulsions, tremor, abdominal and muscle cramps, vomiting and sweating), have occurred following abrupt discontinuance of chlordiazepoxide.
  • The more severe withdrawal symptoms have usually been limited to those patients who had received excessive doses over an extended period of time.
  • Generally milder withdrawal symptoms (eg, dysphoria and insomnia) have been reported following abrupt discontinuance of benzodiazepines taken continuously at therapeutic levels for several months.
  • Consequently, after extended therapy, abrupt discontinuation should generally be avoided and a gradual dosage tapering schedule followed.
  • Addiction-prone individuals (such as drug addicts or alcoholics) should be under careful surveillance when receiving chlordiazepoxide or, other, psychotropic agents because of the predisposition of such patients to habituation and dependence.

What drugs interact with Librium (chlordiazepoxide)?

No information provided.

Treatment & Diagnosis

Medications & Supplements

FDA Logo

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Medically Reviewed on 1/22/2021
References
FDA Prescribing Information

Professional side effects, drug interactions, and addiction sections courtesy of the U.S. Food and Drug Administration.